Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RECOLOR

Financiado

Cerrado

Regulation and consequences of LRRK2 phosphorylation a path to Parkinson s dise...

Regulation and consequences of LRRK2 phosphorylation a path to Parkinson s disease therapy and diagnostics Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, currently incurable. Studies in the PD field show that leucine-rich repeat kinase 2 (LRRK2) is both a major player in PD pathogenesis and a promising... ver más

31/05/2017

UNIVERSITE DE LILL...

185K€

Presupuesto del proyecto: 185K€

Líder del proyecto

UNIVERSITE DE LILLE No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-05-31

MSCA-IF-2014-EF: Marie Skłodowska-Curie Individual F...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITE DE LILLE

185.08K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

SAF2017-89402-R RELACION ENTRE LRRK2 Y EL DEFICIT DE TRAFICO VESICULAR MEDIA... 169K€ Cerrado

MEFOPA European Project on Mendelian Forms of Parkinson s Disease 8M€ Cerrado

SAF2014-58653-R ESTUDIOS DE LA ENFERMEDAD DE PARKINSON ASOCIADA A LRRK2 PARA... 194K€ Cerrado

PARNANT Pathogenetic pathways in age related neurodegenerations as n... 183K€ Cerrado

PARTHECOM New pathway and small-molecule compounds for Parkinson’s dis... 216K€ Cerrado

PID2019-109046GA-I00 REDES GENETICAS REGULADORAS EN LA ENFERMEDAD DE PARKINSON 143K€ Cerrado

Duración del proyecto: 25 meses Fecha Inicio: 2015-04-21
Fecha Fin: 2017-05-31

Líder del proyecto

UNIVERSITE DE LILLE No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 185K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, currently incurable. Studies in the PD field show that leucine-rich repeat kinase 2 (LRRK2) is both a major player in PD pathogenesis and a promising PD therapeutic target. LRRK2 functions in health and disease are not defined; however the applicant and others have shown that LRRK2 phosphorylation is the key to understanding LRRK2 biology. This project’s goal is therefore to understand the role of LRRK2 phosphorylation in PD by pursuing 3 specific aims: 1) elucidate the regulation of LRRK2 phosphorylation by phosphatases, 2) determine LRRK2 phosphorylation downstream phenotypes in cellular models through transcriptome profiling, protein translation profiling and protein tau related phenotypes, and 3) verify these findings from experimental models in PD biosamples. The project builds on the applicant’s extensive expertise in the field of LRRK2 biology (24 papers in 8 years) required for aim 1 and will leverage expertise on PD biosample analysis of the host institution (training for aims 2 and 3). The research program will be performed at the JPA research center (a mixed Inserm-Lille 2 University-Lille University Hospital center for excellence research, Lille, France), with a network of strategically chosen collaborating research groups locally and internationally, coordinated by the applicant. The study of LRRK2 phosphorylation in experimental models and translation of experimental results to clinical samples will reveal the most relevant molecular mechanisms of LRRK2 in PD which can be exploited in follow up work as diagnostic biomarkers and targeted for disease-modifying therapy. Given the importance of PD and neurodegeneration in Europe, this project is fertile ground for a high visibility fellowship and will reposition the applicant in the international neurodegenerative diseases research community by adding a clinical translation dimension to his signalling neurobiologist profile.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores